Seaport Therapeutics, Inc. Common Stock
NASDAQ:SPTXBiotechnology
+$0.10 today
- Market cap
- $980.14M
- Beta
- 0.00
Volume 0.68M
Average 0.41M
SPTX Effect of Forex Changes
Change in reported cash caused by exchange-rate movements on foreign-currency balances.
Effect of Forex Changes history
Currency unavailable · from the cash flow
No Effect of Forex Changes data reported for this period type.
Effect of Forex Changes vs competitors
How SPTX compares with its peers on the latest reported figures
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $2.91M USD | +3883.4% | +264.2% | — | |
LBRXLB Pharmaceuticals Inc Common Stock | LTM Mar 2026 | $264K USD | — | — | — |
| LTM Mar 2026 | $83K USD | -17.0% | -26.3% | 0.0% | |
RAPPRapport Therapeutics, Inc. Common Stock | LTM Mar 2026 | $0 USD | — | — | 0.0% |
CTNMContineum Therapeutics, Inc. Class A Common Stock | LTM Mar 2026 | $0 USD | — | — | — |
| LTM Mar 2026 | $0 USD | +100.0% | — | — | |
NMRANeumora Therapeutics, Inc. Common Stock | LTM Mar 2026 | $0 USD | — | — | — |
SPTXSeaport Therapeutics, Inc. Common Stock | — | — | — | — | — |
| Peer median (excluding SPTX) | — | +100.0% | +119.0% | 0.0% | |
Competitors are the stored peer set for SPTX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Seaport Therapeutics, Inc. Common Stock
NASDAQ:SPTX
Intrinsic Alpha fair value
Locked
Current Price
$18.31
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.